MiNK Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MiNK Therapeutics generated cash of -$15,762,512, which is more than the previous year. Cash used in financing activities reached the amount of -$407,173 last year. Net change in cash is therefore -$16,268,496.
Cash Flow
| 2019 | -14.94M | -426.46K | 11.43M |
|---|---|---|---|
| 2020 | -8.33M | -95.21K | 11.10M |
| 2021 | -12.82M | -248.98K | 49.25M |
| 2022 | -18.86M | -250.04K | -155.59K |
| 2023 | -15.76M | -73.56K | -407.17K |
INKT Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 19.63M | 38.88M | 2.69M | 299.03K | 4.35M |
Operating activities | |||||
Net income | -22.45M | -27.99M | -30.21M | -16.23M | -23.80M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 204.61K | 121.74K | 77.96K | 55.06K | 36.81K |
Stock-based compensation expense | 3.86M | 3.02M | 1.74M | 87.82K | 219.57K |
| Deferred income tax benefit | 3.86M | 3.02M | 1.74M | 87.82K | 219.57K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 1.80M | 3.43M |
Inventories | 0 | 0 | 0 | -1.80M | -3.43M |
Accounts payable | -1.91M | 2.66M | -152.04K | 607.85K | 886.66K |
Cash generated by operating activities | -15.76M | -18.86M | -12.82M | -8.33M | -14.94M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -73.56K | -250.04K | -248.98K | -95.21K | -426.46K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -73.56K | -250.04K | -248.98K | -95.21K | -426.46K |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 39.79M | 901 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -477.63K | -157.19K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -9.45M | -11.10M | 11.43M |
Cash used in financing activities | -407.17K | -155.59K | 49.25M | 11.10M | 11.43M |
Net Change In Cash | -16.26M | -19.25M | 36.19M | 2.39M | -4.05M |
Cash at end of period | 3.36M | 19.63M | 38.88M | 2.69M | 299.03K |
| Data source | Data source | Data source |